PLTR vs PPCB · P/E 584, rev $4.48B vs P/E 0.0, $3.9M cap
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
PPCB does not have a complete income-statement cache yet.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the PLTR and PPCB stock pages for the full models.
Not investment advice.